Establishes central registry for sickle cell trait diagnoses; provides for informational outreach and genetic counseling.
This bill (S 3322) requires New Jersey to create a central registry for newborns diagnosed with sickle cell trait - a genetic condition where a person carries one sickle cell gene but typically does not have sickle cell disease. It mandates that newborn screening labs notify physicians, who must then provide parents with information about genetic counseling. The registry will track cases to ensure parents receive timely notifications during early adolescence (for athletic safety) and later adolescence (for reproductive planning), while keeping all health data confidential. The bill directly affects newborns with sickle cell trait and their families in New Jersey.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 5, 2026
Last action Feb 5, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Feb 5, 2026
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Shirley Turner
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 3322
Scope: NJ
Hi! I can help you understand S 3322. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline